DÜSSELDORF, Germany – Cardio Phoenix, a pioneer in AI-powered medical technologies, today announced a highly successful exhibition of Cardio-HART at MEDICA 2025. By showcasing its flagship innovation, Cardio-HART, in the event’s dedicated Start-up Park, the company secured more than 250 high-quality leads, confirming strong international demand for accessible, hospital-level cardiac diagnostics in primary care settings.
Cardio-HART at MEDICA 2025 Highlights Strong Global Interest
The trade fair, held in Düsseldorf from November 17 to 20, attracted 78,000 trade visitors from 160 countries, with three-quarters of attendees in top management roles. Amidst this global audience, Cardio Phoenix exhibited in the MEDICA Start-up Park (Hall 12), a sector described by organisers as a “central hotspot for future health tech” and a “crowd pleaser” throughout the event. The presence of Cardio-HART at MEDICA 2025 reinforced the device’s relevance among innovators seeking advanced cardiac diagnostics for point-of-care use.
Innovation Meets Immediate Commercial Demand Visitors seeking the next generation of medical technology identified Cardio-HART at MEDICA 2025 as a solution. The device, which functions as an “Echo for Primary Care” by combining AI-reported ECG, eStethoscope, and Echocardiogram capabilities, was enthusiastically received by clinicians.
How Cardio-HART at MEDICA 2025 Captured Demand Across Regions
The technology’s immediate impact was highlighted by a notable interaction on the exhibition floor. Dr Milum, a visiting cardiologist, congratulated Cardio Phoenix inventor Marc Bisnaire after a live demonstration. “Wow, you really did it,” Dr Milum remarked, before placing an order on the spot.
Transforming Care in Low-to-Middle Income Countries Beyond commercial sales, Cardio-HART attracted significant interest from humanitarian and global health leaders seeking solutions for resource-constrained environments.
The team received notable interest from EMERGENCY, the Italian NGO known for providing free, high-quality medical and surgical care to victims of war, landmines, and poverty. Representatives recognised Cardio-HART’s potential to enhance diagnostic precision in settings where standard echocardiography is often unavailable or prohibitively costly.
Furthermore, Gayatri Singh, Founder director – Rayos comprehensive care centres and health care reforms, engaged with the Cardio Phoenix team and identified the device as a scalable solution for low- to middle-income countries (LMICs).
“Our mission is to make effective heart care affordable and accessible to all,” said Marc Bismaire, CEO and Founder of Cardio Phoenix. “The interest from major healthcare providers in India and humanitarian organisations like EMERGENCY confirms that Cardio-HART addresses a critical unmet need: providing hospital-level precision at the point of care, anywhere in the world.“
Expanding Horizons The exhibition highlighted robust demand across the European Union, where Cardio-HART is already fully compliant. Furthermore, the event served as a launchpad for broader international expansion. Cardio Phoenix successfully engaged with key compliance specialists, manufacturers, and distributors to facilitate market entry into India and South America, which were identified as key emerging regions for the company.
About Cardio Phoenix Since 2005, Cardio Phoenix has been dedicated to revolutionising heart disease detection. Backed by over 15 years of scientific research, the company’s AI-enabled Cardio-HART system supports GPs with clinical-grade decision-making tools, improving patient outcomes and optimising referrals.
